Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals

Regulatory Toxicology and Pharmacology : RTP
J F ContreraJoseph J DeGeorge

Abstract

The results of rat and mouse carcinogenicity studies for 282 human pharmaceuticals in the FDA database were analyzed and compared as part of an International Conference on Harmonization (ICH) evaluation of rodent carcinogenicity studies and their utility for carcinogenicity testing. A majority of the carcinogenicity studies in the FDA database were carried out in Sprague-Dawley-derived rats and Swiss-Webster-derived CD-1 mice in contrast to Fisher 344 rats and B6C3F1 mice employed in National Toxicology Program (NTP) studies. Despite the differences in rodent strains, the relative proportion of compounds with positive findings (44.3%) and the degree of overall concordance between rats and mice (74.1%) in the FDA database were similar to the NTP rodent carcinogenicity database. Carcinogenicity studies in two rodent species are necessary primarily to identify trans-species tumorigens, which are considered to pose a relatively greater potential risk to humans than single species positive compounds. Two-year carcinogenicity studies in both rats and mice may not be the only means of identifying trans-species tumorigens. Sufficient experience is now available for some alternative in vivo carcinogenicity models to support their applic...Continue Reading

References

Mar 1, 1992·Risk Analysis : an Official Publication of the Society for Risk Analysis·W W PiegorschD G Hoel
Jul 5, 1991·Science·M HollsteinC C Harris
Nov 22, 1991·Science·J M Adams, S Cory
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Dec 20, 1990·Nature·B Vogelstein
Oct 1, 1994·Prenatal Diagnosis·J E CleaverG H Thomas
Jun 1, 1996·Regulatory Toxicology and Pharmacology : RTP·D A FreedmanT H Lin
Dec 1, 1995·Regulatory Toxicology and Pharmacology : RTP·G M GrayR Wilson
Mar 1, 1961·Cancer·G PIETRAP SHUBIK

❮ Previous
Next ❯

Citations

Sep 17, 2004·Journal of Toxicology and Environmental Health. Part a·John YoungRalph Kodell
Oct 19, 2001·Toxicological Sciences : an Official Journal of the Society of Toxicology·S M CohenJ MacDonald
May 6, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Karol L Thompson, Frank D Sistare
Aug 10, 2011·Journal of Cheminformatics·Varun Khanna, Shoba Ranganathan
Aug 5, 2003·Environmental Health Perspectives·Mark T D CroninAndrew P Worth
May 26, 1998·Environmental Health Perspectives·B Schwetz, D Gaylor
Apr 16, 1998·Environmental Health Perspectives·J F Contrera, J J DeGeorge
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Edwin J Matthews, Joseph F Contrera
Feb 1, 2014·Journal of Pharmaceutical Sciences·Matthias G Wacker
Apr 26, 2011·Regulatory Toxicology and Pharmacology : RTP·Anita Friedrich, Klaus Olejniczak
Nov 18, 2004·Basic & Clinical Pharmacology & Toxicology·Carol S Auletta
Apr 26, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Armen H Tashjian, David Goltzman
Dec 22, 2009·Molecular Nutrition & Food Research·Luis G ValerioR Daniel Benz
Jul 27, 2004·Journal of Chemical Information and Computer Sciences·Hongmao Sun
Aug 30, 2013·Critical Reviews in Toxicology·David A EastmondBabasaheb Sonawane
Nov 14, 1997·Regulatory Toxicology and Pharmacology : RTP·T J FlammangP P Fu
Nov 9, 2000·Regulatory Toxicology and Pharmacology : RTP·B Silva Lima, J W Van der Laan
Mar 28, 2012·Regulatory Toxicology and Pharmacology : RTP·Jan Willem van der LaanAldert Piersma
Nov 30, 2013·Regulatory Toxicology and Pharmacology : RTP·Palma Ann MaroneA Wallace Hayes
Apr 27, 2016·Critical Reviews in Toxicology·Jan Willem van der LaanMarkku Pasanen
Dec 17, 2016·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·E L AndradeJ B Calixto
Jun 15, 2007·Toxicologic Pathology·Paul Baldrick, Lesley Reeve
Dec 16, 1997·Molecular Carcinogenesis·B Schwetz, D Gaylor
Dec 19, 2002·Environmental Health Perspectives·Steve Wing, David Richardson
Dec 4, 2002·Environmental Health Perspectives·Frank M Johnson, James Huff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.